Cell Genesys Starts More Trials for Immunotherapy
Posted by rob on May 11, 2007 under Uncategorized | 
Be the First to Comment
Cell Genesys have started three new clinical The trials are now under way in
trials for GVAX immunotherapy for leukemia, following encouraging
results in a phase II study.
collaboration with the Johns Hopkins Sidney Kimmel Cancer Center in
patients with chronic myelogenous leukemia (CML). The studies include a
new phase II trial, an extension of the original phase II trial, and a
new phase I trial.
Add A Comment
You must be logged in to post a comment.